Cisplatin treatment was found to promote an increase in the expression of IFNγ, enhance endothelial cell glycolysis and lactic acid production, promote VE-cadherin endocytosis, and promote the disruption of tumour vascular integrity. This evidence concerns the gene IFNG and neoplasm.